A study on the effect of "Sasahealth" used for oral mucositis associated with the anti-cancer agent administratio
Not Applicable
Recruiting
- Conditions
- Oral mucositis which was developed by the side effects of anti-cancer drug therapy for lung cancer
- Registration Number
- JPRN-UMIN000022003
- Lead Sponsor
- Saitama Medical Center Saitama Medical University. Department of Oral and MaxillofacialSurgery.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1. Subjects who have an inappropriate clinical history for efficacy and safety assessment in the study (such as drug poisoning, alcoholism, and the disease of heart, liver, kidney, lungs, eye, blood etc) 2.Any history for drug allergy 3. Subjects within three months after the participation to other clinical trials 4.Subjects who are inadequate for enrollment judged by the investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.The evaluation of oral mucositis after "Sasahealth" p.o. 2.The searching for inflammatory markers (IL-6, IL-8, etc.)in the saliva after "Sasahealth" p.o.
- Secondary Outcome Measures
Name Time Method 1.Safety assessment(adverse event) 2.Diary described 3.Questionnaire survey